Pharmacogenomics and antidepressant drugs

Author： Binder* Elisabeth   Holsboer Florian  

Publisher： Informa Healthcare

ISSN： 0785-3890

Source： Annals of Medicine, Vol.38, Iss.2, 2006-04, pp. : 82-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rational Use of Antidepressant Drugs

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 4, 2014-06 ,pp. : 197-204

Karger

Access to resources Recommend Favorite

What are tricyclic antidepressant drugs [letter]?

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 2, Iss. 1, 1975-02 ,pp. : 93-94

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacogenomics

By  

Pancreatology, Vol. 8, Iss. 1, 2008-01 ,pp. : 4-5

Karger

Access to resources Recommend Favorite

Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies

By  

Molecular Neuropsychiatry, Vol. 1, Iss. 3, 2015-0 ,pp. : 145-155

Karger

Access to resources Recommend Favorite

Application of TDM, pharmacogenomics and biomarkers for neurological disease pharmacotherapy: focus on antiepileptic drugs

By Clarke William   McMillin Gwen  

Personalized Medicine, Vol. 3, Iss. 2, 2006-05 ,pp. : 139-149

Future Medicine

Access to resources Recommend Favorite